PAVmed Inc (PAVM) has released an update.
PAVmed Inc. has announced a significant reward for its shareholders: a special pro rata dividend distribution of roughly 3.3 million shares, constituting 6.9% of Lucid Diagnostics’ common stock. Following this generous distribution, PAVmed will retain a substantial 65.2% ownership in Lucid Diagnostics, demonstrating both a sharing of value with its investors and a continued commitment to its majority-owned subsidiary.
For further insights into PAVM stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
